Physician profile
Stephen A Phillips
NPI 1972702561
$10,265.15
in general payments reported to CMS, 2019-2025
18 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,553 · 2020: $260 · 2021: $499 · 2022: $7,623 · 2023: $182 · 2024: $22.36 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $330.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,603.68 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $143.11 | 2019-2023 | Keytruda, Lynparza |
| Merit Medical Systems INC | $94.70 | 2020-2025 | Savi Scout |
| Davol INC. | $80.54 | 2019-2020 | |
| Tela Bio, INC. | $68.60 | 2020-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $35.04 | 2020 | |
| Braintree Laboratories, INC. | $31.89 | 2022-2025 | Suflave |
| Hologic Sales and Service, LLC | $31.41 | 2023-2025 | Coolseal Generator, Brevera Breast Biopsy System |
| Takeda Pharmaceuticals U.S.A., INC. | $31.06 | 2025 | Gattex |
| Pacira Pharmaceuticals Incorporated | $24.72 | 2025 | Exparel |
| Phathom Pharmaceuticals, INC. | $22.36 | 2024 | Voquezna |
| Cook Medical LLC | $18.22 | 2019 | |
| Acell, INC. | $16.99 | 2020 | |
| Medtronic, INC. | $14.28 | 2021 | |
| Zyla Life Sciences, INC. | $12.86 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $12.40 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $12.08 | 2020 | |
| Integra Lifesciences Corporation | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.